Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema

Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema

Blog Article

Ravdeep Kaur, Aerik Anthony Williams, Catherine Baker Swift, Jason W Caldwell Wake Forest University School of Medicine, Wake Forest University, Winston-Salem, NC, USA Abstract: Acquired angioedema is often associated PEPPERMINT OIL with significant morbidity.An underlying lymphatic malignancy, autoimmune disorder, adenocarcinoma, or other malignancy may be present.Screening for these disorders should occur in all patients with acquired angioedema as treatment may result in Shaker resolution of angioedema.

Keywords: complement, C1-INH deficiency, ecallantide, hemopathy.